Computer Aided Detection (CADe) of Neoplasia during Colonoscopy - “GI Genius”
Department of Veterans Affairs · VHA: Veterans Health Administration
Overview
- Development stage
- DeployedSource: c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
- High-impact designation
- High-impactSource: a) High-impact
- Impact justification
- Not reported
- Start date
- Not reported
- Withheld from public reporting
- Not reported
Mission
- Topic area
- Health and Medical
- Operational functions
- No function tag matched Derived by keyword rules; see methodology
Problem the AI is intended to solve
The device improves endoscopy quality by aiding neoplastic lesion detection during procedures. Multiple studies and meta-analyses have found these devices increase adenoma detection rates (ADR), a well-established metric for colonoscopy quality that is related to colon cancer incidence and death. Randomized implementation of the devices across VHA facilities allowed for a pragmatic evaluation of the impact of these devices on ADR. The evaluation demonstrated that the provision of colonoscopy Computer Aided Detection devices resulted in a statistically significant 21% increase in the odds of adenoma detection and an absolute increase in ADR of approximately 4% compared to colonoscopy without CADe.
Expected benefits
These devices demonstrably improve endoscopy quality within the VHA, which in turn improves outcomes for Veterans, ultimately reducing morbidity and mortality. Multiple studies and meta-analyses have found these devices increase adenoma detection rates (ADR), a well-established metric for colonoscopy quality that is related to colon cancer incidence and death. Randomized implementation of the devices across VHA facilities allowed for a pragmatic evaluation of the impact of these devices on ADR. The evaluation demonstrated that the provision of colonoscopy Computer Aided Detection devices resulted in a statistically significant 21% increase in the odds of adenoma detection and an absolute increase in ADR of approximately 4% compared to colonoscopy without CADe.
System outputs
During endoscopy, the CADe device automatically detects, and highlights suspected neoplastic lesions / polyps in real time. A highlighted rectangle automatically surrounds suspected lesions. No results or data are tracked or automatically documented. The device physically connects to existing endoscopes, video processors, and display monitors, but does not connect to the VA network.
Technology
- AI classification
- Computer visionSource: Computer Vision: AI that processes and interprets visual data (e.g., images and videos).
- System name(s)
- Not reported
- Custom-developed code
- No
- Public source code
- www.medtronic.com ↗
Sourcing
- How it was built
- Purchased from vendorSource: a) Purchased from a vendor
- Vendor (as reported)
- Not reported
- Vendors (standardized)
- None on the standard list
A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.
Data and privacy
- Involves PII
- Not reported
- Privacy Impact Assessment
- Not reported
- Authorization to Operate
- Not reported
- Demographic features
- Not reported
- Training and evaluation data
- Not reported
- Federal Data Catalog
- Not reported
Governance
0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.
Potential impacts and how they were identified
Not reported